St. Rókus Hospital
About St. Rókus Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Henogen
2
Pfizer
2
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
1
Resverlogix Corp
1
Clinical Trials at St. Rókus Hospital
During the past decade, St. Rókus Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
2006-02-01
2007-03-01
Completed
300
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
2007-03-01
2009-11-01
Completed
102
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
2016-07-01
2022-03-31
Completed
2,499
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Rókus Hospital"
#1 collaborator was "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator, "General University Hospital, Prague" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at St. Rókus Hospital
According to Clinical.Site data, the most researched conditions in "St. Rókus Hospital" are
"Cardiovascular Disease" (3 trials), "Hepatitis B" (2 trials), "Coronary Artery Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "St. Rókus Hospital" in a lesser frequency.
Clinical Trials Intervention Types at St. Rókus Hospital
Most popular intervention types in "St. Rókus Hospital" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials) and "Cardiovascular Polypill" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Rókus Hospital
The vast majority of trials in "St. Rókus Hospital" are
6 trials for "All" genders.
Clinical Trials Status at St. Rókus Hospital
Currently, there are NaN active trials in "St. Rókus Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in St. Rókus Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in St. Rókus Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".